Structures by: Sema Ö. Y.
Total: 36
6-Nitro-1-(2-phenylethyl)-1H-benzimidazole
C15H13N3O2
Acta Crystallographica Section E (2005) 61, 7 o2038-o2039
a=6.6382(6)Å b=11.4258(6)Å c=18.2702(16)Å
α=90° β=107.039(7)° γ=90°
(2-exo,7-exo,9-exo,10-exo)-11-oxatricyclo[6.2.1.0^2,7^]undec-4-ene-9,10-diyl diacetate
C14H18O5
Acta Crystallographica Section E (2005) 61, 6 o1677-o1679
a=13.9144(13)Å b=5.5055(4)Å c=17.8016(17)Å
α=90° β=107.858(8)° γ=90°
3-Benzyl-4-(4-methylphenyl)-1H-1,2,4-triazole-5(4H)-thione
C16H15N3S
Acta Crystallographica Section E (2004) 60, 12 o2281-o2283
a=12.3833(12)Å b=7.2297(5)Å c=15.8926(15)Å
α=90° β=95.488(7)° γ=90°
3-Ethyl-1-[2-(1-ethylmorpholinium-1-yl)ethyl]benzimidazolium diiodide monohydrate
C17H27N3O2,2I,H2O
Acta Crystallographica Section E (2005) 61, 2 o301-o303
a=7.527(5)Å b=24.889(5)Å c=11.757(5)Å
α=90° β=106.007(5)° γ=90°
2,3,4,6-Tetra-O-acetyl-N-(2-hydroxybenzylidene)-β-D-galactopyranosylamine
C21H25NO10
Acta Crystallographica Section E (2006) 62, 5 o2069-o2071
a=7.8014(4)Å b=15.2381(11)Å c=19.1271(10)Å
α=90° β=90° γ=90°
(5-Methylisoxazol-3-yl)[2-(5-methylisoxazol-3-yl)-2,3-dihydro-1H-isoindol- 1-ylidene]amine
C16H14N4O2
Acta Crystallographica Section E (2006) 62, 6 o2226-o2228
a=13.5698(8)Å b=7.8257(6)Å c=13.6527(8)Å
α=90° β=100.690(4)° γ=90°
1-Methoxyethyl-5-nitrobenzimidazole
C10H11N3O3
Acta Crystallographica Section E (2005) 61, 9 o2804-o2805
a=4.7940(7)Å b=8.4531(13)Å c=13.411(2)Å
α=97.350(12)° β=94.854(12)° γ=101.266(12)°
1-[2-(1,3-Benzothiazol-2-ylimino)imidazolidin-1-yl]ethanone
C12H12N4OS
Acta Crystallographica Section E (2006) 62, 5 o1870-o1871
a=7.31240(10)Å b=7.93120(10)Å c=21.0085(3)Å
α=90° β=93.2710(10)° γ=90°
4-Phenyl-3-(pyridin-4-yl)-1H-1,2,4-triazole-5(4H)-thione
C13H10N4S
Acta Crystallographica Section E (2005) 61, 3 o619-o621
a=11.2958(6)Å b=12.7480(8)Å c=17.5607(8)Å
α=90° β=90° γ=90°
(2-exo,7-exo,9-endo,10-endo)-11-Oxatricyclo[6.2.1.0^2,7^]undec-4-ene-9,10-diyl diacetate
C14H18O5
Acta Crystallographica Section E (2005) 61, 3 o760-o762
a=5.8430(3)Å b=12.8501(8)Å c=17.5767(11)Å
α=90° β=97.449(5)° γ=90°
Methyl 2-oxo-2,3-dihydro-1,3-benzothiazole-3-acetate
C10H9NO3S
Acta Crystallographica Section E (2005) 61, 11 o3872-o3873
a=4.7858(3)Å b=12.4010(7)Å c=17.5319(10)Å
α=90° β=95.679(5)° γ=90°
Methyl [6-amino-5-cyano-4-(4-methoxyphenyl)pyrano[2,3-c]pyrazol-3-yl]acetate
C17H16N4O4
Acta Crystallographica Section E (2005) 61, 12 o4206-o4208
a=6.2806(8)Å b=9.9148(12)Å c=13.6958(16)Å
α=90.813(10)° β=97.042(10)° γ=108.051(9)°
Diethyl 2-(3,4-dicyanophenyl)-2-[(2-naphthyl)methyl]malonate
C26H22N2O4
Acta Crystallographica Section E (2005) 61, 12 o4101-o4103
a=15.3760(3)Å b=11.5504(2)Å c=26.0798(5)Å
α=90° β=90° γ=90°
5-Nitro-1-(2-piperidinoethyl)-1H-benzimidazole
C14H18N4O2
Acta Crystallographica Section E (2006) 62, 3 o922-o924
a=6.3202(2)Å b=10.1321(4)Å c=12.4362(5)Å
α=104.109(3)° β=103.953(2)° γ=102.546(2)°
3,3'-Bis(3-methylbut-2-enyl)-1,1'-propylenedibenzimidazolium dibromide monohydrate
C27H34N42,2Br,H2O
Acta Crystallographica Section E (2006) 62, 8 o3512-o3514
a=8.7777(4)Å b=12.0851(7)Å c=14.4078(7)Å
α=106.966(4)° β=96.868(4)° γ=104.747(4)°
6-Methyl-N-(3-oxo-1-thia-4-azaspiro[4.4]non-4-yl)imidazo[2,1-b][1,3]thiazole- 5-carboxamide monohydrate
C14H16N4O2S2,H2O
Acta Crystallographica Section E (2005) 61, 8 o2357-o2359
a=12.959(5)Å b=10.908(5)Å c=23.797(5)Å
α=90° β=90° γ=90°
3,3'-Bis(cyclohexylmethyl)-1,1'-propylenedibenzimidazolium dibromide monohydrate
C31H42N42,2Br,H2O
Acta Crystallographica Section E (2006) 62, 8 o3184-o3186
a=9.2538(5)Å b=12.5925(8)Å c=15.4610(9)Å
α=105.049(5)° β=105.593(4)° γ=110.034(4)°
N-(2-Hydroxy-3-methoxybenzylidene)-2,3,4,6-tetra-O-acetyl-β-D- galactopyranosylamine
C22H27NO11
Acta Crystallographica Section E (2006) 62, 8 o3247-o3248
a=8.6855(7)Å b=7.6735(5)Å c=18.5577(15)Å
α=90° β=97.124(7)° γ=90°
5-(2-Furyl)-4-(4-methoxyphenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione
C13H11N3O2S
Acta Crystallographica Section E (2004) 60, 12 o2368-o2370
a=7.0789(6)Å b=8.4650(6)Å c=21.4774(13)Å
α=90° β=96.492(5)° γ=90°
6-Methyl-N'-(1-methylethylidene)imidazo[2,1-b][1,3]thiazole-5-carbohydrazide monohydrate
C10H12N4OS,H2O
Acta Crystallographica Section E (2005) 61, 3 o718-o720
a=10.0955(7)Å b=9.8500(6)Å c=13.3756(8)Å
α=90° β=111.226(5)° γ=90°
N-(2,2-Dimethyl-4-oxo-1,3-thiazolidin-3-yl)-6- methylimidazo[2,1-b][1,3]thiazole-5-carboxamide monohydrate
C12H14N4O2S2,H2O
Acta Crystallographica Section E (2005) 61, 4 o892-o894
a=11.3660(7)Å b=21.4096(12)Å c=12.9034(11)Å
α=90° β=90° γ=90°
Poly[[triaquacadmium(II)-μ~3~-lactato] dilactatoboron(1-)]
C3H11CdO6,C6H8BO6
Acta Crystallographica Section E (2005) 61, 4 m632-m634
a=8.424(5)Å b=10.184(5)Å c=20.943(5)Å
α=90° β=90° γ=90°
N-(4-Chlorophenyl)-N-(4,5-dihydro-1H-imidazol-2-yl)amine formamide solvate
C9H10ClN3,CH3NO
Acta Crystallographica Section E (2007) 63, 5 o2130-o2132
a=8.5840(5)Å b=13.2740(4)Å c=9.9080(7)Å
α=90° β=105.789(5)° γ=90°
(1,3-Benzothiazol-2-yl)[1-(2-chlorobenzyl)imidazolidin-2-ylidene]amine
C17H15ClN4S
Acta Crystallographica Section E (2006) 62, 9 o3812-o3813
a=20.0595(3)Å b=10.6269(2)Å c=15.0647(2)Å
α=90° β=97.5720(10)° γ=90°
C37H31N3O2
C37H31N3O2
Acta Crystallographica Section E (2006) 62, 11 o5022-o5023
a=11.6063(7)Å b=14.8988(6)Å c=19.4799(11)Å
α=90° β=121.552(4)° γ=90°
1,2-bis(2-aminophenoxy)ethane
C14H16N2O2
Acta Crystallographica Section E (2007) 63, 1 o331-o332
a=7.0644(6)Å b=7.5770(7)Å c=23.8053(10)Å
α=90° β=90° γ=90°
2-[(2-furylmethyl)sulfanyl]-1H-3,1-benzimidazol-3-ium chloride dihydrate
C12H11N2OS,Cl,2(H2O)
Acta Crystallographica Section E (2007) 63, 5 o2433-o2433
a=7.0649(6)Å b=21.5994(17)Å c=9.5520(7)Å
α=90° β=97.925(6)° γ=90°
Methyl 2-[(1-oxo-1<i>H</i>-isochromen-3-yl)methyl]benzoate
C18H14O4
Acta Crystallographica Section E (2007) 63, 6 o2824-o2824
a=8.1628(7)Å b=8.8981(8)Å c=11.0236(9)Å
α=105.048(7)° β=108.266(6)° γ=97.981(7)°
Rubidium(I) monensinate dihydrate
C36H61O11Rb,2(H2O)
Acta Crystallographica Section E (2008) 64, 1 m154-m155
a=12.5298(15)Å b=16.361(2)Å c=19.342(2)Å
α=90° β=90° γ=90°
1-[(4-Methylbenzylidene)amino]-5-(4-methylbenzoyl)-4-(p-tolyl)pyrimidin- 2(1H)-one
C27H23N3O2
Acta Crystallographica Section E (2007) 63, 4 o1857-o1858
a=13.9829(7)Å b=12.0458(7)Å c=16.4807(9)Å
α=90° β=125.831(3)° γ=90°
Diethyl 2-[morpholin-4-yl(phenyl)methyl]malonate
C18H25NO5
Acta Crystallographica Section E (2007) 63, 4 o1656-o1657
a=9.1421(6)Å b=11.5978(7)Å c=17.1379(15)Å
α=90° β=90° γ=90°
Dimethyl N-(4-phenyl-1,3-thiazol-2-yl)dithioimidocarbonate
C12H12N2S3
Acta Crystallographica Section E (2006) 62, 9 o3902-o3903
a=7.66260(10)Å b=18.2969(3)Å c=19.4176(3)Å
α=90° β=90° γ=90°
5-(4-Methylbenzoyl)-4-(4-methylphenyl)-1-[(1-phenylethylidene)amino]pyrimidin- 2(1H)-one
C27H23N3O2
Acta Crystallographica Section E (2007) 63, 4 o1712-o1713
a=13.6001(7)Å b=17.1608(10)Å c=10.8703(5)Å
α=90° β=111.351(4)° γ=90°
5,5a-Diallyl-5,5a,13,14-tetrahydro-12H-di-1,3- benzimidazolo[1,2-a;1',2'-c][1,4]diazepine
C23H24N4
Acta Crystallographica Section E (2006) 62, 12 o5697-o5698
a=25.1810(13)Å b=8.304(5)Å c=8.878(8)Å
α=90° β=90° γ=90°
1,3-Bis(2-chlorobenzoyl)-3,4,5,6-tetrahydropyrimidine-2(1H)-thione
C18H14Cl2N2O2S
Acta Crystallographica Section E (2006) 62, 9 o3697-o3698
a=11.361(5)Å b=12.917(5)Å c=12.186(5)Å
α=90° β=95.399(5)° γ=90°
N-(2-{[(1E)-1-(2-Hydroxyphenyl)ethylidene]amino}phenyl)-2-methoxyacetamide
C17H18N2O3
Acta Crystallographica Section E (2007) 63, 8 o3478-o3479
a=8.4061(8)Å b=11.2568(5)Å c=16.4145(16)Å
α=90° β=98.988(8)° γ=90°